List of articles with "Eli Lilly"

Lilly at JPM Healthcare

Lilly at JPM Healthcare

USA Indianapolis Healthcare Conference J.P. Morgan Eli Lilly
Inluriyo Efficacy Update

Inluriyo Efficacy Update

USA Indianapolis Eli Lilly Verzenio Inluriyo
Lilly's $6 Billion Facility

Lilly's $6 Billion Facility

United States Huntsville Eli Lilly API Manufacturing
Lilly Acquires Adverum

Lilly Acquires Adverum

United States Indianapolis gene therapy Eli Lilly Adverum
Jaypirca Efficacy Remarkable

Jaypirca Efficacy Remarkable

USA Indianapolis CLL/SLL Eli Lilly Jaypirca
Lilly's 2026 Dividend Announced

Lilly's 2026 Dividend Announced

United States Dividend Indianapolis Eli Lilly 2026
Bertozzi Back at Lilly

Bertozzi Back at Lilly

United States Indianapolis Eli Lilly Nobel Prize Carolyn Bertozzi
Lilly's SABCS Highlights

Lilly's SABCS Highlights

United States San Antonio Eli Lilly Verzenio Inluriyo
Jaypirca at ASH 2025

Jaypirca at ASH 2025

United States Orlando Eli Lilly CLL Jaypirca
Waltz Health's New Model

Waltz Health's New Model

USA Chicago Novo Nordisk Eli Lilly Waltz Health
Virginia's Pharma Workforce Boost

Virginia's Pharma Workforce Boost

United States AstraZeneca Richmond Eli Lilly VIPC
Eli Lilly Transformation

Eli Lilly Transformation

USA healthcare Baltimore Eli Lilly Dave Ricks
Lilly Gateway Labs

Lilly Gateway Labs

United States Philadelphia Eli Lilly Lilly Gateway Labs Breakthrough Properties
Lilly's New Gateway Labs

Lilly's New Gateway Labs

USA Philadelphia Eli Lilly Lilly Gateway Labs
Lilly at Citi 2025

Lilly at Citi 2025

USA Indianapolis Healthcare Conference Eli Lilly Ilya Yuffa
ObesityWeek 2025: Innovations

ObesityWeek 2025: Innovations

United States Atlanta Eli Lilly CagriSema ObesityWeek
Insilico & Lilly Collaboration

Insilico & Lilly Collaboration

United States Cambridge Eli Lilly Insilico Medicine AI Drug Discovery
Eli Lilly Leadership Updates

Eli Lilly Leadership Updates

United States Indianapolis Eli Lilly Carole Ho Adrienne Brown
Lilly Expands Obesity Drugs Access

Lilly Expands Obesity Drugs Access

United States Indianapolis Obesity Medications Zepbound Eli Lilly
Promise of Eloralintide

Promise of Eloralintide

USA Indianapolis Eli Lilly Obesity Treatment eloralintide
Ailux and Lilly Team Up

Ailux and Lilly Team Up

China Shanghai Eli Lilly XtalPi Ailux
Lilly's $3 Billion Expansion

Lilly's $3 Billion Expansion

Manufacturing Netherlands Eli Lilly Katwijk
Lilly's New Facility

Lilly's New Facility

Manufacturing Netherlands Eli Lilly Katwijk
Lilly's Q3 2025 Update

Lilly's Q3 2025 Update

United States Indianapolis Zepbound Eli Lilly Mounjaro
Lilly's $1.2B Investment

Lilly's $1.2B Investment

United States Puerto Rico Eli Lilly Carolina oral medicines
Lilly's $1.2B Investment

Lilly's $1.2B Investment

United States Puerto Rico Eli Lilly Carolina Drug Manufacturing
Lilly and Team USA Unite

Lilly and Team USA Unite

United States Indianapolis Eli Lilly Team USA Olympic Games
Omvoh FDA Approval

Omvoh FDA Approval

United States Indianapolis Ulcerative Colitis Eli Lilly Omvoh
Eli Lilly Dividend Q4 2025

Eli Lilly Dividend Q4 2025

United States Dividend Indianapolis pharmaceuticals Eli Lilly
Lilly Acquires Adverum

Lilly Acquires Adverum

United States Indianapolis Eli Lilly Adverum Biotechnologies Ixo-vec
GLP-1 Agonists Market

GLP-1 Agonists Market

United States Delray Beach Novo Nordisk GLP-1 Agonists Eli Lilly
Promising Diabetes Treatment

Promising Diabetes Treatment

United States Indianapolis Eli Lilly Type 2 Diabetes Orforglipron
Alzheimer's Diagnostic Improvements

Alzheimer's Diagnostic Improvements

Brussels Belgium Alzheimer's Disease Eli Lilly diagnostic pathways
Urgent Action for Alzheimer

Urgent Action for Alzheimer

None diagnostics Eli Lilly Alzheimer
Alzheimer Diagnostics Urgent Call

Alzheimer Diagnostics Urgent Call

Brussels Belgium Alzheimer's Disease Eli Lilly diagnostic gaps
Alzheimer's Diagnostic Gaps

Alzheimer's Diagnostic Gaps

None healthcare Brussels Alzheimer's Disease Eli Lilly
Omvoh: Four-Year Efficacy

Omvoh: Four-Year Efficacy

United States Indianapolis Ulcerative Colitis Eli Lilly Omvoh
Lilly Gateway Labs San Diego

Lilly Gateway Labs San Diego

United States San Diego Eli Lilly Gateway Labs
Inluriyo Approved

Inluriyo Approved

United States Indianapolis Breast Cancer Eli Lilly Inluriyo
Lilly's $6.5 Billion Facility

Lilly's $6.5 Billion Facility

United States Houston Eli Lilly Pharmaceutical Manufacturing Orforglipron
Mounjaro in Pediatrics

Mounjaro in Pediatrics

United States Indianapolis tirzepatide Eli Lilly Mounjaro
Orforglipron vs Semaglutide

Orforglipron vs Semaglutide

USA Indianapolis Semaglutide Eli Lilly Orforglipron
Eli Lilly's Orforglipron Success

Eli Lilly's Orforglipron Success

USA Indianapolis Eli Lilly Orforglipron ATTAIN-1
Lilly's Big Move

Lilly's Big Move

United States Manufacturing Virginia Eli Lilly Goochland
Lilly at Healthcare Forum

Lilly at Healthcare Forum

Eli Lilly Lucas Montarce Healthcare Forum
Lilly's TuneLab Launch

Lilly's TuneLab Launch

United States Indianapolis AI Platform Eli Lilly TuneLab
Alchemab ATLX-1282 Trial

Alchemab ATLX-1282 Trial

Cambridge United Kingdom Eli Lilly Alchemab ATLX-1282
Gaucher's Disease Market

Gaucher's Disease Market

USA Las Vegas Eli Lilly Sanofi Gaucher's Disease
FDA Breakthrough for Olomorasib

FDA Breakthrough for Olomorasib

United States Indianapolis FDA Eli Lilly Olomorasib
Verzenio® EBC Success

Verzenio® EBC Success

USA Indianapolis Breast Cancer Eli Lilly Verzenio

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.